BMS-599626
≥98%
- Product Code: 77824
CAS:
714971-09-2
| Molecular Weight: | 530.56 g./mol | Molecular Formula: | C₂₇H₂₇FN₈O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD10565678 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
BMS-599626 is primarily investigated for its potential in cancer therapy, particularly as an inhibitor of specific kinases involved in tumor growth and progression. It targets HER1 and HER2 receptors, which are often overexpressed in various cancers, including breast, lung, and gastric cancers. By inhibiting these receptors, BMS-599626 disrupts signaling pathways that promote cancer cell proliferation and survival. This makes it a candidate for targeted therapy in patients with HER1/HER2-positive malignancies. Research focuses on its efficacy in preclinical models and its potential use in combination with other anticancer agents to enhance therapeutic outcomes. Its role in overcoming resistance to existing treatments is also under exploration.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to Light yellow to Light orange powder to crystal |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿4,491.00 |
+
-
|
| 0.010 | 10-20 days | ฿7,902.00 |
+
-
|
BMS-599626
BMS-599626 is primarily investigated for its potential in cancer therapy, particularly as an inhibitor of specific kinases involved in tumor growth and progression. It targets HER1 and HER2 receptors, which are often overexpressed in various cancers, including breast, lung, and gastric cancers. By inhibiting these receptors, BMS-599626 disrupts signaling pathways that promote cancer cell proliferation and survival. This makes it a candidate for targeted therapy in patients with HER1/HER2-positive malignancies. Research focuses on its efficacy in preclinical models and its potential use in combination with other anticancer agents to enhance therapeutic outcomes. Its role in overcoming resistance to existing treatments is also under exploration.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :